Information on the Target

Volare, a Finnish biotechnology company, has successfully raised €26 million in funding to establish the Volare 01 factory in Pori, making it the world's most energy-efficient protein production facility. This groundbreaking plant aims to advance Volare's unique insect protein technology to industrial scale, significantly contributing to European food security, protein independence, and sustainable industry practices. The funding round welcomed both domestic and international investors, including Maki.vc, Firstminute Capital, Springvest, Ilmastorahasto (integrating into Tesi), Finnvera, Business Finland, Norion Bank, and the South Ostrobothnia ELY Centre.

Industry Overview in Finland

According to the European Commission, the EU is currently only 34% self-sufficient in high-protein animal feeds (with over 30% protein content). This low self-sufficiency makes the food system vulnerable to supply disruptions and price fluctuations. Finland, as a part of the EU, faces similar challenges in ensuring a stable and sustainable food supply.

The shift towards circular economy solutions is increasingly imperative for tackling these issues. Volare's scalable production model positions it as a key player in enhancing local food security and sustainability, especially by utilizing by-products from the food industry that would otherwise contribute to waste.

With the rise in demand for sustainable and alternative protein sources, growing interest in insect protein has emerged. The global market for insect-based food products is expected to expand significantly, driven by both consumer demand for eco-friendly options and the need for innovative protein solutions as traditional sources face limitations.

Furthermore, the agricultural sector in Finland is gradually recognizing the potential of insect protein in both animal and human nutrition. This aligns well with Volare's mission of implementing a sustainability-centered approach, which resonates with the increasing consumer preference for environmentally friendly food options.

The Rationale Behind the Deal

The strategic funding will facilitate Volare's transition into a new growth phase while establishing the Volare 01 factory as a cornerstone of sustainable protein production. The partnership with various investors underscores the shared confidence in Volare's innovative approach to bioreactor technology, which leverages the black soldier fly (Hermetia illucens) to convert food industry by-products into valuable raw materials.

This investment not only aims to enhance production capacity but also supports Europe's objective of achieving greater food security and reducing dependence on imported protein sources. Volare’s model promises a reduction in energy consumption by up to 30% compared to conventional production methods, contributing to a more sustainable future.

Information About the Investor

The investment consortium is a mix of prominent Finnish and international venture capital firms and financial institutions. These players are keen on supporting innovations that align with sustainability and environmental stewardship. Maki.vc and Firstminute Capital, established investors in the European startup ecosystem, have a history of backing companies that lead in technological advancements and sustainable practices.

The involvement of Business Finland further indicates strong governmental backing for innovative Finnish companies. This is pivotal in fostering an ecosystem that promotes sustainable development and addresses pressing global issues within the food production chain, enhancing the overall competitiveness of Finland's agriculture sector.

View of Dealert

The investment in Volare appears to be a strategic move within the wider context of sustainability and food security. Given the increasing global emphasis on alternative protein sources, Volare's unique and scalable insect protein technology stands to benefit immensely. The reduction in energy usage and the waste-free production model positions Volare favorably within the market.

Moreover, Volare’s successful participation in the initial stages of the food supply chain, demonstrated by partnerships with firms like Skretting, reinforces its potential for growth. With the first pilot batch of fish raised on Volare protein already on the market, this establishes a precedent and paves the way for broader acceptance and market penetration.

However, as with any new technology, the road ahead may face challenges such as regulatory hurdles, market acceptance, and competition from traditional protein sources. The ability of Volare to continually innovate and adapt will be critical in maintaining its competitive edge.

In conclusion, the investment in Volare not only signifies confidence in its technological prowess but also aligns with the urgent need for sustainable food production methods. If executed effectively, this could very well position Volare as a leader in the insect protein industry, contributing significantly to both local and global food systems.

View Original Article

Similar Deals

Northern Gritstone Apini

2025

Other VC Biotechnology & Medical Research United Kingdom
Mubadala Capital Tenvie Therapeutics

2025

Other VC Biotechnology & Medical Research United States of America
Avadel Pharmaceuticals plc XWPharma Ltd.

2025

Other VC Biotechnology & Medical Research Other
磐霖资本 丹擎医药

2025

Other VC Biotechnology & Medical Research China
Biostate AI Biostate AI

2025

Other VC Biotechnology & Medical Research Other
British Patient Capital Dementia Discovery Fund 2 (DDF-2)

2025

Other VC Biotechnology & Medical Research United Kingdom
Alzheimer’s Drug Discovery Foundation Transposon Therapeutics

2025

Other VC Biotechnology & Medical Research United States of America
Addex Therapeutics Stalicla SA

2025

Other VC Biotechnology & Medical Research Switzerland
New World Angels Aegle Therapeutics

2025

Other VC Biotechnology & Medical Research United States of America

Maki.vc, Firstminute Capital, Springvest, Ilmastorahasto, Finnvera, Business Finland, Norion Bank, Etelä-Pohjanmaan ELY-keskus

invested in

Volare

in 2025

in a Other VC deal

Disclosed details

Transaction Size: $28M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert